Integrated bioinformatics analysis and experimental validation reveal Pevonedistat as a promising therapeutic agent modulating the CRL4-DTL-p21/p53 axis in nasopharyngeal carcinoma.
Journal:
Hereditas
Published Date:
Mar 7, 2026
Abstract
No abstract available for this article.
Authors
Keywords
No keywords available for this article.
